Phastar And Beaconcure Announce Partnership To Deliver Process Revolution In Clinical Data Review

By Author: Orson Amiri
Total Articles: 397
Comment this article

Beaconcure Inc. and Phastar Inc. have formed a strategic partnership to revolutionize clinical trial processes. Beaconcure's AI-enabled clinical data validation technology, combined with Phastar's expertise in biometrics, aims to streamline trial development, expediting lifesaving drug delivery. Ilan Carmeli, COO of Beaconcure, lauded the collaboration for enhancing efficiency and transparency through Verify, Phastar's new collaboration platform. Ping-Chung Chang, Phastar's Head of Business Transformation, emphasized the partnership's impact on accelerating treatment access, improving data integrity, and optimizing workflow management.

Christine Oliver, Beaconcure's CEO, highlighted their joint commitment to innovation in clinical research, leveraging Phastar's expertise to set new industry standards. Phastar, an esteemed biometrics CRO, prioritizes quality and timely delivery across its global operations, ensuring excellence in clinical research. Beaconcure's Verify platform reinforces this commitment, offering a secure workspace for AI-driven clinical study analysis validation, reducing errors, and enhancing efficiency for biopharmaceutical companies and CROs alike.

Read More - https://www.techdogs.com/tech-news/business-wire/phastar-and-beaconcure-announce-partnership-to-deliver-process-revolution-in-clinical-data-review